Bodogai et al. [73] indicated that cancer-induced Bregs fully mobilized the immunomodulatory and tumor-promoting function of MDSCs, which are manifested by the increase of ROS and NO, inhibiting the CD4+ and CD8+ T cell proliferation. The gene discussed is CD4; the disease is neoplasm.